• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

H1 Acquires London-Based Faculty Opinions to Broaden Global Doctor Network

by Fred Pennic 02/16/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
H1 Acquires London-Based Faculty Opinions to Broaden Global Doctor Network

What You Should Know:

H1, a global healthcare professional data ecosystem to enable life sciences, academic medical institutions, health systems, and payors acquires London-based Faculty Opinions Ltd, formerly known as Faculty of 1000 and F1000 Prime.  Financial details of the acquisition were not disclosed.

– A close partner of H1, Faculty Opinions fuses the comments and opinions of thousands of top researchers in the Life and Medical Sciences to highlight and validate the most exciting and important research in biology and medicine that is emerging today. Users across Life Sciences, Academic Medical Institutions, Research organizations and more access these insights to drive their respective fields forward.


Find the most important research in Biology and Medicine

Faculty Opinions helps academic institutions, laboratories, biopharma companies, and researchers stay abreast of the latest developments in science; support funding strategy and policy; identify emerging areas and influential researchers; and discover which research from their institutions is being recommended. H1’s expansive doctor network will now have the ability to discover research findings, develop ideas, and collaborate in the spirit of improving the world of medicine and scientific research.

H1 currently offers the industry’s premier healthcare data ecosystem for Healthcare Providers (HCPs). H1’s HCP Universe platform shines a light on the power of key opinion leader influence across life sciences companies, hospitals, academic medical centers and health systems. Seven of the top 10 pharmaceutical companies in the world and several leading academic medical centers (Columbia, UPenn, and others) use H1 to connect with providers, find clinical research, locate industry experts, launch clinical trials, and benchmark their organizations. The acquisition of Faculty Opinions will provide H1’s clients with a unique lens through which to identify key opinion leaders.

“We could not be more excited to welcome Faculty Opinions and their amazing team to the H1 family. Acquiring Faculty Opinions is an important evolution that allows us to continue growth as a go-to source for healthcare professionals, while also providing unique access to the latest discourse within the scientific community,” said Ariel Katz, co-founder and CEO of H1.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: clinical research, Clinical Trials, global healthcare, H1, Health Systems, Healthcare Data, Healthcare Mergers & Acquisitions, Life Sciences, Premier

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |